Published in Am J Nephrol on September 05, 2007
The Labile Side of Iron Supplementation in CKD. J Am Soc Nephrol (2015) 0.85
Elevation of Interleukin-18 Correlates With Cardiovascular, Cerebrovascular, and Peripheral Vascular Events: A Cohort Study of Hemodialysis Patients. Medicine (Baltimore) (2015) 0.77
Systemic Redox Imbalance in Chronic Kidney Disease: A Systematic Review. Oxid Med Cell Longev (2016) 0.76
Renal function in patients with non-dialysis chronic kidney disease receiving intravenous ferric carboxymaltose: an analysis of the randomized FIND-CKD trial. BMC Nephrol (2017) 0.75
Oxidative stress is progressively enhanced with advancing stages of CKD. Am J Kidney Dis (2006) 1.44
Sodium-glucose cotransporter-2 inhibitors and blood pressure decrease: a valuable effect of a novel antidiabetic class? J Hypertens (2015) 1.42
Association between hyperhomocysteinemia and ultrasonographic atherosclerotic indices of carotid arteries in chronic hemodialysis patients. Nephron Clin Pract (2005) 1.41
Intervention Associated Acute Kidney Injury and Long-Term Cardiovascular Outcomes. Am J Nephrol (2015) 1.39
Beneficial effects of oral magnesium supplementation on insulin sensitivity and serum lipid profile. Med Sci Monit (2010) 1.27
Metabolic syndrome in children and adolescents with acute lymphoblastic leukemia after the completion of chemotherapy. J Pediatr Hematol Oncol (2005) 1.16
The controversial effects of thiazolidinediones on cardiovascular morbidity and mortality. Int J Cardiol (2008) 1.14
Effects of low-dose atorvastatin on arterial stiffness and central aortic pressure augmentation in patients with hypertension and hypercholesterolemia. Am J Hypertens (2013) 1.12
Increase in oxidative stress but not in antioxidant capacity with advancing stages of chronic kidney disease. Am J Nephrol (2007) 1.11
Microalbuminuria and chronic kidney disease as risk factors for cardiovascular disease. Nephrol Dial Transplant (2006) 1.07
Carvedilol in hypertension treatment. Vasc Health Risk Manag (2008) 1.02
Effects of thiazolidinediones beyond glycaemic control. Curr Pharm Des (2009) 0.93
Gender disparity in outcomes of care and management for diabetes and the metabolic syndrome. Curr Diab Rep (2006) 0.93
Oral magnesium supplementation reduces ambulatory blood pressure in patients with mild hypertension. Am J Hypertens (2009) 0.92
Lipid profile, low-density lipoprotein oxidation and ceruloplasmin in the progeny of families with a positive history of cardiovascular diseases and/or hyperlipidemia. Angiology (2009) 0.91
Differences between office and 24-hour blood pressure control in hypertensive patients with CKD: A 5,693-patient cross-sectional analysis from Spain. Am J Kidney Dis (2013) 0.91
Hemodialysis reduces augmentation index but not aortic or brachial pulse wave velocity in dialysis-requiring patients. Am J Nephrol (2011) 0.89
Are saturated fatty acids and insulin resistance associated with fatty liver in obese children? Clin Nutr (2008) 0.87
Arterial stiffness: a novel cardiovascular risk factor in kidney disease patients. Curr Vasc Pharmacol (2015) 0.85
Ambulatory blood pressure monitoring: an invaluable tool comes of age for patients with chronic kidney disease? Am J Nephrol (2012) 0.85
Amelioration of cardiovascular risk factors with partial biochemical control of acromegaly. Clin Endocrinol (Oxf) (2008) 0.83
Blood pressure and serum potassium levels in hypertensive patients receiving or not receiving antihypertensive treatment. Clin Exp Hypertens (2007) 0.82
Total protein, albumin and low-molecular-weight protein excretion in HIV-positive patients. BMC Nephrol (2012) 0.81
Microalbuminuria. Clin Lab Med (2006) 0.80
Compliance with a structured weight loss program is associated with reduced systolic blood pressure in obese patients with chronic kidney disease. Am J Hypertens (2012) 0.80
Total serum homocysteine, folate and vitamin B12 in a Greek school age population. Clin Nutr (2006) 0.80
Diabetic nephropathy: Endothelin antagonism for diabetic nephropathy. Nat Rev Nephrol (2010) 0.80
The impact of diabetic autonomic neuropathy on the incretin effect. Med Sci Monit (2008) 0.80
Elevated asymmetric dimethylarginine is associated with oxidant stress aggravation in patients with early stage autosomal dominant polycystic kidney disease. Kidney Blood Press Res (2014) 0.79
Diverse effects of interdialytic intervals on central wave augmentation in haemodialysis patients. Nephrol Dial Transplant (2013) 0.79
The involvement of uric acid in the pathogenesis of preeclampsia. Curr Hypertens Rev (2015) 0.78
Prevalence of Hyperkalemia in Diabetic and Non-Diabetic Patients with Chronic Kidney Disease: A Nested Case-Control Study. Am J Nephrol (2015) 0.78
Does evidence support renin-angiotensin system blockade for slowing nephropathy progression in elderly persons? Ann Intern Med (2009) 0.78
Severe hyperlipidemia in a child with acute lymphoblastic leukemia treated with L-asparaginase and prednisone. Pediatr Int (2004) 0.78
Metabolic effects of beta-blockers: importance of dissociating newer from conventional agents. J Hypertens (2007) 0.78
ACE gene insertion/deletion polymorphism and renal scarring in children with urinary tract infections. Pediatr Nephrol (2009) 0.78
Lipid profile of children with a family history of coronary heart disease or hyperlipidemia: 9-year experience of an outpatient clinic for the prevention of cardiovascular diseases. Angiology (2005) 0.77
Use of a single target blood pressure level in type 2 diabetes mellitus for all cardiovascular risk reduction: comment on "intensive and standard blood pressure targets in patients with type 2 diabetes mellitus". Arch Intern Med (2012) 0.77
Effects of renin-angiotensin system inhibition on left atrial function of hypertensive patients: an echocardiographic tissue deformation imaging study. Am J Hypertens (2010) 0.77
Adverse effects of conventional thrice-weekly hemodialysis: is it time to avoid 3-day interdialytic intervals? Am J Nephrol (2015) 0.76
Ambulatory Blood Pressure Monitoring in the Diagnosis, Prognosis, and Management of Resistant Hypertension: Still a Matter of our Resistance? Curr Hypertens Rep (2015) 0.76
Common features and differences of the hypothalamic-pituitary-gonadal axis in male and female. Gynecol Endocrinol (2014) 0.76
A cost-effectiveness analysis of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in diabetic nephropathy. J Clin Hypertens (Greenwich) (2007) 0.76
A reappraisal of renin-angiotensin system blockade on microalbuminuria development: do they offer anything unique? J Hypertens (2012) 0.75
Metabolic syndrome and arterial stiffness: evidence for gender disparity and early effects of non-traditional risk factors? J Hypertens (2007) 0.75
Renin-angiotensin system blockade and exercise-induced increase in aortic stiffness. J Clin Hypertens (Greenwich) (2014) 0.75
What lies behind the intense criticism of ALLHAT? J Hypertens (2004) 0.75
Is there any association between high-density lipoprotein, insulin resistance and non-alcoholic fatty liver disease in obese children? Int J Food Sci Nutr (2009) 0.75
Microscopic hematuria in adolescents and young adults and risk for end-stage renal disease. JAMA (2011) 0.75
Sustained hypotension complicating an extra-adrenal pheochromocytoma. Am J Hypertens (2008) 0.75
Hemodiafiltration does not have additional benefits over hemodialysis on arterial stiffness, wave reflections and central aortic pressures. Blood Purif (2014) 0.75
Blood pressure variability is increasing from the first to the second day of the interdialytic interval in hemodialysis patients. J Hypertens (2017) 0.75
Apelin levels in normal pregnancy. Clin Endocrinol (Oxf) (2011) 0.75
Effect of hospitalization on 24-h ambulatory blood pressure of hypertensive patients. Hypertens Res (2010) 0.75
Familial burden of hypertension and its effect on blood pressure levels, insulin resistance, and intracellular ions in Greek offspring. J Am Soc Hypertens (2008) 0.75
Enterococcus faecalis: an unusual cause of meningitis in a child with non-Hodgkin lymphoma. Turk J Pediatr (2008) 0.75
Rosiglitazone and cardiovascular risk: weighing recent evidence. J Cardiometab Syndr (2007) 0.75
Oral calcium supplementation ambulatory blood pressure and relation to changes in intracellular ions and sodium-hydrogen exchange. Am J Hypertens (2009) 0.75